Ben Harshbarger
General Counsel bei ASTRIA THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Benjamin J.
Harshbarger is currently the Chief Legal Officer at Astria Therapeutics, Inc. He previously held positions as the Chief Executive Officer & General Counsel at Novelion Therapeutics, Inc., Senior Director-Corporate Counsel at Cubist Pharmaceuticals LLC, Senior Director-Deputy General Counsel at ViaCell, Inc., Associate General Counsel at Biogen, Inc., General Counsel at Aegerion Pharmaceuticals, Inc., and Associate at Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC.
He obtained his undergraduate degree from the University of Richmond and his graduate degree from Boston College Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Ben Harshbarger
| Unternehmen | Position | Beginn |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | General Counsel | 12.06.2020 |
Ehemalige bekannte Positionen von Ben Harshbarger
| Unternehmen | Position | Ende |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Chief Executive Officer | 31.12.2019 |
| AEGERION PHARMACEUTICALS, INC. | General Counsel | 01.07.2016 |
| CUBIST PHARMACEUTICALS INC | General Counsel | 01.03.2012 |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.03.2008 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2006 |
Ausbildung von Ben Harshbarger
| University of Richmond | Undergraduate Degree |
| Boston College Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Commercial Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
